06/03/2023at 09:59

Demand for Novo Nordisk's Wegovy accelerating

Prescriptions for the obesity treatment in the US have grown 11% week-on-week.

by marketwire, translated by daniel pedersen

Prescription numbers in the US for Novo Nordisk’s newest obesity drug, Wegovy (semaglutide), still indicate a strong underlying growth, assesses analyst at Danish bank Sydbank Søren Løntoft Hansen.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

Access all locked articles
Receive our daily newsletters
Access our app

Get full access for you and your coworkers

Start a free company trial today

Novo Nordisk's Wegovy sales in US still rising – albeit at slower pace
For subscribers
Bernie Sanders urges Novo Nordisk and Sanofi to follow Eli Lilly's example: Drop insulin prices
For subscribers
Global obesity costs expected to double to USD 4.27trn by 2035
For subscribers

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Front page now

Antibiotic Dicillin has infected Danish and Icelandic patients Antibiotikummet Dicillin har smittet både danskere og islændinge med multiresistente bakterier, som patienterne sandsynligvis skal leve med resten af livet. | Foto: Lægemiddelstyrelsen / Pr

Pharma & biotech

Sandoz severs ties with European CMO – Dicillin permanently withdrawn from market

Sandoz ends its collaboration with the secret CMO that made the contaminated antibiotic product and cannot rule out other drugs could be infected with multi-resistant bacteria.

For subscribers

Både danskere og islændinge har nu multiresistente bakterier i kroppen efter at have spist antibiotikummet Dicillin. | Foto: Lægemiddelstyrelsen / Pr

Other

Denmark: Violation of good manufacturing practice is source of contaminated antibiotic

For subscribers

Pharma & biotech

Analyst: New Novo Nordisk data sets the bar high for diabetes pills

For subscribers

Pharma & biotech

Zealand Pharma presents positive early-stage results for weight-loss candidate

For subscribers

Pharma & biotech

Genmab promotes senior VP for strategy to executive management

For subscribers

Medtech

Ambu wins European approval of two fifth-generation bronchoscopes

For subscribers

Sandoz severs ties with European CMO – Dicillin permanently withdrawn from market

Sandoz ends its collaboration with the secret CMO that made the contaminated antibiotic product and cannot rule out other drugs could be infected with multi-resistant bacteria.

For subscribers

Pharma & biotech

Analyst: New Novo Nordisk data sets the bar high for diabetes pills

Despite promising results, one analyst thinks patients will have to wait for higher doses of diabetes pill Rybelsus until 2025.

For subscribers

Pharma & biotech

Wegovy prescriptions in the US grow for another week

Although Novo Nordisk’s obesity treatment grew less than in prior weeks, one bank still detects the presence of strong underlying demand.

For subscribers

Demand for Novo Nordisk's Wegovy accelerating

Read the whole article

With your free trial you get:

Get full access for you and your coworkers

Related articles:

Novo Nordisk's Wegovy sales in US still rising – albeit at slower pace

Bernie Sanders urges Novo Nordisk and Sanofi to follow Eli Lilly's example: Drop insulin prices

Global obesity costs expected to double to USD 4.27trn by 2035

Sign up for our newsletter

Front page now

Sandoz severs ties with European CMO – Dicillin permanently withdrawn from market

Denmark: Violation of good manufacturing practice is source of contaminated antibiotic

Analyst: New Novo Nordisk data sets the bar high for diabetes pills

Zealand Pharma presents positive early-stage results for weight-loss candidate

Genmab promotes senior VP for strategy to executive management

Ambu wins European approval of two fifth-generation bronchoscopes

Further reading

Sandoz severs ties with European CMO – Dicillin permanently withdrawn from market

Analyst: New Novo Nordisk data sets the bar high for diabetes pills

Wegovy prescriptions in the US grow for another week

Jobs